Delivery Order SPE2DB24D8003-SPE2DB25FJTNP
Award Date
12/30/24
Potential Completion Date
12/31/24
Potential Value
$9.5K
Federal Agency
Defense Logistics Agency
Awardee
Dakota Drug, Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This contract award, valued at $1,524.99, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of Fluticasone-Salmeterol 115-21 12GM, a pharmaceutical product. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and an ultimate completion date of February 13, 2025. Dakota Drug, Inc. holds a larger, single-award Indefinite Delivery Contract (IDC) with the DLA, valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business that specializes in providing pharmaceutical products, medical supplies, and healthcare equipment to the U.S. federal government. The contract, valued at $7,225.70, is a firm fixed-price delivery order for the supply of Fluticasone-Salmeterol 115-21 12GM inhalers. The award is associated with a larger Indefinite Delivery Contract (IDC) between Dakota...
This federal contract award, valued at $2,698.33, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is a delivery order for Fluticasone-Salmeterol 230-21 12GM, a pharmaceutical product, with a performance period ending on March 8, 2024. Dakota Drug, Inc. is a key supplier to the DLA's Troop Support Medical division, holding a $999,999,999.00 Indefinite Delivery Contract (IDC) as part of the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $2,437.20 firm fixed-price delivery order contract is for the supply of Fluticasone-Salmeterol 115-21 12GM, a pharmaceutical product. The contract has an ultimate completion date of June 3, 2024. Dakota Drug, Inc. is an established vendor in the federal medical supply market, holding a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, identified as SPE2DB24D8002|SPE2DB25FJNAW, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, with a ceiling value of $2,553.05, is for the delivery of FLUTICASONE-SALMETEROL 230-21 12GM, a prescription pharmaceutical product. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of January 28, 2025. It is not designated as a set-aside contract. Dakota Drug,...
This federal contract award, valued at $4,206.61, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of 4566601984 units of the pharmaceutical product Fluticasone-Salmeterol 115-21 12GM, a respiratory medication used to treat asthma and chronic obstructive pulmonary disease (COPD). The contract has a firm fixed-price delivery order structure and an ultimate completion date of December 4, 2024....
This contract award, identified as SPE2DX15D8002|SPE2DX24F2WN0, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $4,274.76 firm fixed-price delivery order is for the provision of fluticasone-salmeterol 230-21 12GM, a pharmaceutical product used for respiratory conditions. The award is not associated with a larger contract vehicle, and there is no set-aside designation. Dakota Drug, Inc. is the prime contractor, and there...
This federal contract award, identified as SPE2DB24D8002|SPE2DB24FJMPU, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Dakota Drug, Inc. The contract is a firm fixed-price delivery order for the delivery of pharmaceutical products, specifically Fluticasone-Salmeterol 115-21 12GM. The total ceiling value of the contract is $1,256.94, and the ultimate completion date is July 18, 2024. Dakota Drug, Inc. is a self-certified small disadvantaged...
This contract award, with ID SPE2DB24D8003|SPE2DB24FJTJA, is a Firm Fixed Price Delivery Order issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $1,988.44 order is for the supply of the pharmaceutical product Fluticasone-Salmeterol 230-21 12GM. This award is part of a larger Indefinite Delivery Contract (IDC) held by Dakota Drug, Inc. with the DLA, identified as SPE2DB24D8001, which has a ceiling value of $999,999,999.00. The...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract, valued at $2,538.99, is for the delivery of the pharmaceutical product fluticasone-salmeterol 500-50 60s. This award is associated with Dakota Drug, Inc.'s Indefinite Delivery Contract (IDC) SPE2DB24D8001, valued at $999,999,999.00, which allows...